Detalhe da pesquisa
1.
Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation.
Proc Natl Acad Sci U S A
; 118(8)2021 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33602823
2.
Comparable transforming growth factor beta-mediated immune suppression in ex vivo-expanded natural killer cells from cord blood and peripheral blood: implications for adoptive immunotherapy.
Cytotherapy
; 24(8): 802-817, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35589475
3.
Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes.
BMC Genomics
; 18(1): 132, 2017 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28166722
4.
Integrative genomic analysis in K562 chronic myelogenous leukemia cells reveals that proximal NCOR1 binding positively regulates genes that govern erythroid differentiation and Imatinib sensitivity.
Nucleic Acids Res
; 43(15): 7330-48, 2015 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26117541
5.
Vitamin D receptor and RXR in the post-genomic era.
J Cell Physiol
; 230(4): 758-66, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25335912
6.
Cooperative behavior of the nuclear receptor superfamily and its deregulation in prostate cancer.
Carcinogenesis
; 35(2): 262-71, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24104552
7.
Clinical and immunological relevance of SLAMF6 expression in the tumor microenvironment of breast cancer and melanoma.
Sci Rep
; 14(1): 2394, 2024 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287061
8.
The predominant Quillaja Saponaria fraction, QS-18, is safe and effective when formulated in a liposomal murine cancer peptide vaccine.
J Control Release
; 369: 687-695, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575073
9.
Identification of Enhanced Vaccine Mimotopes for the p15E Murine Cancer Antigen.
Cancer Res Commun
; 4(4): 958-969, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506662
10.
Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency.
Front Immunol
; 15: 1297338, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38495876
11.
A senescence-mimicking (senomimetic) VEGFR TKI side-effect primes tumor immune responses via IFN/STING signaling.
Mol Cancer Ther
; 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38690835
12.
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas.
Cancer Res Commun
; 4(5): 1268-1281, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38619287
13.
Stratification of Patients with Renal Cell Carcinoma by the Abundance of Sarcomatoid Features Reveals Differences in Survival and the Underlying Pathobiology.
Eur Urol Oncol
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38480032
14.
Epigenetic disruption of the RARγ complex impairs its function to bookmark AR enhancer interactions required for enzalutamide sensitivity in prostate cancer.
bioRxiv
; 2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38168185
15.
JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy.
Mol Cancer Res
; 21(1): 24-35, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36166196
16.
Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency.
bioRxiv
; 2023 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37781631
17.
MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression.
Commun Biol
; 6(1): 1030, 2023 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37821650
18.
Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer.
Front Oncol
; 13: 1120329, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36816919
19.
Predictive and Prognostic Implications of Circulating CX3CR1+ CD8+ T Cells in Non-Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy.
Cancer Res Commun
; 3(3): 510-520, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37009132
20.
The MYC axis in advanced prostate cancer is impacted through concurrent targeting of ERß and AR using a novel ERß-selective ligand alongside Enzalutamide.
bioRxiv
; 2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38014010